Based on their analysis of a mail-in questionnaire, researchers in Canada found that parents who had their daughters vaccinated differed from those who did not do so in perceived susceptibility to the disease, benefits and barriers of the vaccine, and cues to action.
Human Papillomavirus (HPV) is a leading cause of sexually transmitted diseases, with more than 70% of sexually active people getting the virus at least once in their lifetimes. Persistent infection with some HPV strains can lead to cervical cancer, the second most common cancer in women, as well as to head-and-neck and other types of cancer and anogenital warts in both men and women.
Current HPV vaccines have been shown to be safe and virtually 100% efficacious in extensive clinical trials and use in the field, but routine vaccination targeted predominantly at young girls has generated widespread public controversy. Scientists from McGill University, the Lady Davis Institute at the Jewish General Hospital in Montreal, and Institut National de Santé Publique du Québec have identified key determinants in parents' decision-making about HPV vaccination of their daughters. Their results have been published in Human Vaccines & Immunotherapeutics.
774 Quebec parents of 9- to 10-year-old girls eligible to a local free school-based HPV vaccination program responded to a mail-in questionnaire, and their answers were analyzed in the framework of the Health Belief Model, which dissects decision-making into 5 factors: perceived susceptibility to and severity of HPV infection, perceived benefits and barriers of vaccination, and cues to action, ie, external influences promoting vaccination.
Link to the complete article on ScienceDaily: http://bit.ly/1GYLIC4
Research Reveals the Role of Structural Racism in Lung Cancer Risk
December 7th 2023Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.
Read More
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More
Prediction Model Identified Risk Factors for ED Visits in Patients With Lung Cancer
December 7th 2023A risk prediction model that was based on machine learning could help to make resource utilization more efficient by correctly predicting emergency department (ED) visits in patients with lung cancer.
Read More
Negotiations to extend US global HIV/AIDS relief work are deadlocked; the Biden administration delayed its rule on the proposed menthol cigarette ban until March 2024 after lobbying by civil rights groups; federal agencies have partnered with a digital health company to create an at-home test-to-treat program for flu and COVID-19.
Read More